[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Note
April 2000

Resistance to Botulinum Toxin Injections for Spasmodic Dysphonia

Author Affiliations

From the Division of Otolaryngology–Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City (Dr Smith), and the Division of Otolaryngology–Head and Neck Surgery, University of Wisconsin at Madison, Madison (Dr Ford).

Arch Otolaryngol Head Neck Surg. 2000;126(4):533-535. doi:10.1001/archotol.126.4.533
Abstract

A known complication of botulinum toxin injections in the treatment of dystonia has been the occasional development of resistance. This has been seen primarily with patients who receive injections for torticollis. We report on 2 patients who, after several years of receiving injections for spasmodic dysphonia, developed clinical resistance by failing to have expected voice improvement after receiving laryngeal reinjection. One of the 2 patients demonstrated antibodies to botulinum toxin by mouse neutralization bioassay. The second patient had negative bioassay results but had no clinical response to the test toxin injection of facial muscles. These cases demonstrate that, although uncommon, resistance to botulinum toxin injections can occur in the treatment of spasmodic dysphonia. We offer suggestions to limit this complication.

×